Details of the Drug Reposition

Vancomycin DM3JFIH

Vancomycin (oral, MRSA), AuricX; Vancomycin (oral/pill, MSRA); Vancomycin (oral/pill, MSRA), AuricX/SRI International

3D MOL is unavailable

General Information of This Drug (ID: DM3JFIH)

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

7 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Staphylococcus aureus infection	DISK6PTH	N.A.	Approved	[1]
Staphylococcal pneumonia	DIS28ZSZ	N.A.	Approved	[1]
Neonatal sepsis	DIS8Q3VE	N.A.	Approved	[1]
Bacterial endocarditis	DIS920N0	N.A.	Approved	[1]
Methicillin-resistant staphylococci infection	DIS6DRDZ	1A00-1A09	Approved	[2]
Clostridioides difficile infection	DIS1A2OI	1A04	Approved	[1]
Bacteremia	DIS6N9RZ	1A73	Approved	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 7 Indications(s)

1 Withdrawn Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gram-positive bacterial infection	DISZ44JH	1B74-1G40	Withdrawn	[3]
------------------------------------------------------------------------------------

1 Discontinued in Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Staphylococcus infection	DISY8WGS	1B5Y	Discontinued in Phase 3	[4]
------------------------------------------------------------------------------------

2 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
MRSA infection	DISWDJNU	1D01.0Y	Investigative	[5]
Skin infection	DISVYKGN	1F28-1G0Z	Investigative	[1]
------------------------------------------------------------------------------------

References

1	Vancomycin FDA Label
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3	The Effectiveness of Lower Cyclosporine Doses for Psoriasis
4	Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
5	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.